PATH | VRL
Menu

Find resources

Total results with these characteristics: 194

Topic: Immunization financing

Page 2 of 10
A Cost Effectiveness and Capacity Analysis for the Introduction of Universal Rotavirus Vaccination in Kenya: Comparison Between Rotarix and RotaTeq Vaccines

The authors of this article, published in PLoS ONE, applied cost-effectiveness modeling and a cold-chain impact assessment to aid decision-making on rotavirus vaccine introduction in Kenya. They conclude that use of either vaccine is cost-effective, …

Author: van Hoek AJ, Ngama M, Ismail A, et al.

Publication date: 2012

The Cost of Cervical Cancer Prevention in Low- and Lower-Middle-Income Countries

This briefing paper discusses estimates of the cost and health impact of cervical cancer prevention (including human papillomavirus vaccination, screening, and preventive treatment) in countries with a per capita gross domestic product less than …

Author: Cervical Cancer Action

Publication date: 2017

The Cost of Immunization Programs in the Next 10 Years

This paper summarizes the results of a WHO/UNICEF study on the potential impact of immunization over the next decade and the financing required for immunization activities in the 72 poorest countries of the world.

Author: World Health Organization

Publication date: 2006

The Cost Structure of Routine Infant Immunization Services: A Systematic Analysis of Six Countries

This article, published in Health Policy and Planning, describes the results of an analysis of routine infant immunization program cost structures in six low- and middle-income countries. Using a unique dataset of routine infant immunization costs …

Author: Geng F, Suharlim C, Brenzel L, Resch SC, Menzies NA

Publication date: 2017

Cost-Effectiveness Analysis of Typhoid Conjugate Vaccines in Five Endemic Low- and Middle-Income Settings

Typhoid fever remains endemic in low- and middle-income countries, yet programmatic use of existing vaccines is limited. This article, published in Vaccine, evaluates the cost-effectiveness of five typhoid conjugate vaccine (TCV) delivery strategies …

Author: Antillón M, Bilcke J, Paltiel AD, Pitzer VE

Publication date: 2017

Cost-Effectiveness and Economic Benefits of Vaccines in Low- and Middle-Income Countries: A Systematic Review

This review, published in Vaccine, documents the available evidence showing that vaccination in low- and middle-income countries brings important economic benefits. The cost-effectiveness studies reviewed suggest to policy makers that vaccines are …

Author: Ozawa S, Mirelman A, Stack ML, Walker DG, Levine OS

Publication date: 2012

Cost-Effectiveness of a New Rotavirus Vaccination Program in Pakistan: A Decision Tree Model

This article, published in Vaccine, reports on the expected public health impact of a national rotavirus vaccination program in Pakistan by performing a cost-effectiveness study from the perspective of the health care system. Across a range of …

Author: Patel HD, Roberts ET, Constenla DO

Publication date: 2013

Cost-Effectiveness of a Potential Group B Streptococcal Vaccine Program for Pregnant Women in South Africa

No licensed vaccine for group B Streptococcus (GBS) currently exists, but a polysaccharide-protein conjugate vaccine candidate is currently in trials. This article, published in Vaccine, reports the results of a study that evaluated the potential …

Author: Kim S-Y, Russell LB, Park J, et al.

Publication date: 2014

Cost-Effectiveness of Childhood Rotavirus Vaccination in Taiwan

This paper, published in the journal Vaccine, investigates whether routine infant immunization with either currently licensed rotavirus vaccine could be cost-effective in Taiwan. The authors modeled specific disease outcomes …

Author: Wu CL, Yang YC, Huang LM, Chen KT

Publication date: 2009

Cost-effectiveness of Conjugate Meningococcal Vaccination Strategies in the United States

This article, published in the journal Pediatrics, discusses a study to evaluate and compare the projected health and economic impact of meningococcal conjugate A/C/Y/W-135 (MCV-4) vaccination of adolescents, toddlers, and infants in the United …

Author: Shepard CW, Ortega-Sanchez IR, Scott RD 2nd, Rosenstein NE; ABCs Team

Publication date: 2005

Cost-Effectiveness of Female Human Papillomavirus Vaccination in 179 Countries: A PRIME Modelling Study

This article, published in The Lancet Global Health, reports on a modeling study that assessed the cost-effectiveness and health effects of vaccinating girls against human papillomavirus (HPV) before sexual debut in terms of burden of cervical …

Author: Jit M, Brisson M, Portnoy A, Hutubessy R

Publication date: 2014

Cost-Effectiveness of Introducing a Rotavirus Vaccine in Developing Countries: The Case of Mexico

This study, published in BMC Infectious Diseases, developed a model to compare the cost and disease burden of rotavirus in unvaccinated children in Mexico. The study determined that it would be highly cost-effective to include rotavirus vaccine …

Author: Valencia-Mendoza A, Bertozzi SM, Gutierrez JP, Itzler R

Publication date: 2008

Cost-Effectiveness of Japanese Encephalitis Vaccination

This fact sheet summarizes methods and results of cost-effectiveness analyses performed by PATH and its partners to determine the economic implications of introducing JE vaccine programs. The fact sheet is an excerpt from a larger, comprehensive …

Author: PATH

Publication date: 2009

Cost-Effectiveness of Maternal GBS Immunization in Low-Income Sub-Saharan Africa

This article, published in Vaccine, reports the results of a modeling study to evaluate the potential costs and public health impact of a maternal group B Streptococcus (GBS) vaccine, if one is successfully developed. The model projected early-onset …

Author: Russell LB, Kim S-Y, Cosgriff B, et al.

Publication date: 2017

Cost-Effectiveness of Maternal Influenza Immunization in Bamako, Mali: A Decision Analysis

Maternal immunization is a well-established strategy to diminish maternal and neonatal mortality, however it requires a substantial investment, especially in developing countries, to be effective. This article, published in PLoS ONE, reports the …

Author: Orenstein EW, Orenstein LAV, Diarra K, et al.

Publication date: 2017

The Cost-Effectiveness of Rotavirus Vaccination in Armenia

This article, published in Vaccine, evaluates the cost-effectiveness of introducing infant rotavirus vaccination in Armenia in 2012 using Rotarix(R)® using a multiple birth cohort model. The model considered the cost and health implications of …

Author: Jit M, Yuzbashyan R, Sahakyan G, Avagyan T, Mosina L

Publication date: 2011

Cost-Effectiveness of Rotavirus Vaccination in Ghana: Examining Impacts From 2012 to 2031

Ghana introduced rotavirus vaccination as part of routine immunization in 2012, and it has been shown to be effective in reducing disease burden in children under five years. Ghana’s transition from low to lower-middle income status in 2010 …

Author: Nonvignon J, Atherly D, Pecenka C, et al.

Publication date: 2017

Cost-Effectiveness of Routine and Campaign Use of Typhoid Vi-Conjugate Vaccine in Gavi-Eligible Countries: A Modelling Study

This article, published in The Lancet Infectious Diseases, reports the results of a modelling study to evaluate the cost-effectiveness of typhoid conjugate vaccine in low- and middle-income countries with varying typhoid burdens. The study modelled …

Author: Bilcke J, Antillon M, Pieters Z, et al.

Publication date: 2019

Cost-Effectiveness of Routine Immunization to Control Japanese Encephalitis in Shanghai, China

From the Bulletin of the World Health Organization, this article investigates the cost-effectiveness of JE immunization in China and demonstrates that a JE immunization program can be a cost-saving intervention for countries.

Author: Ding D, Kilgore PE, Clemens JD, Liu W, Xu Z

Publication date: 2003

Costing RTS,S Introduction in Burkina Faso, Ghana, Kenya, Senegal, Tanzania, and Uganda: A Generalizable Approach Drawing on Publicly Available Data

This article, published in Vaccine, proposes a generalizable methodology to estimate the cost of introduction of the RTS,S/AS01 malaria vaccine in African countries (Burkina Faso, Ghana, Kenya, Senegal, Tanzania, and Uganda) using routinely …

Author: Galactionova K, Bertram M, Lauer J, Tediosi F

Publication date: 2015

Page 2 of 10